Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

Summary Background Adherence is an overall marker of treatment success, and it depends on multiple factors including efficacy and safety. Despite the wide use of tumour necrosis factor (TNF)‐α blockers in the treatment of plaque‐type psoriasis, few data regarding treatment adherence in routine clini...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2013-09, Vol.169 (3), p.666-672
Hauptverfasser:	Esposito, M., Gisondi, P., Cassano, N., Ferrucci, G., Del Giglio, M., Loconsole, F., Giunta, A., Vena, G.A., Chimenti, S., Girolomoni, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Biological and medical sciences Dermatologic Agents - therapeutic use Dermatology Etanercept Female Humans Immunoglobulin G - therapeutic use Immunologic Factors - therapeutic use Infliximab Kaplan-Meier Estimate Male Medical sciences Medication Adherence Middle Aged Psoriasis - drug therapy Psoriasis - mortality Psoriasis. Parapsoriasis. Lichen Receptors, Tumor Necrosis Factor - therapeutic use Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!